Stockreport

Insmed Impresses With Pulmonary Portfolio, But Still Lacks Remedy To Turn A Profit [Seeking Alpha]

Insmed, Inc.  (INSM) 
Last insmed, inc. earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF INSM's pipeline, including the recent FDA approval of BRINSUPRI and many pre-clinical programs, underpins future growth potential in its role within pulmonary disease, [Read more]